HCFA Relaxes Grip On MCAC, Allowing Informal Comment On Coverage
This article was originally published in The Gray Sheet
Executive SummaryThe Health Care Financing Administration is giving its Medicare Coverage Advisory Committee a wider berth in discussing whether or not a device warrants Medicare coverage during reviews by the various panels.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.